omeprazole has been researched along with Duodenal Diseases in 15 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Duodenal Diseases: Pathological conditions in the DUODENUM region of the small intestine (INTESTINE, SMALL).
Excerpt | Relevance | Reference |
---|---|---|
" Our purpose was to evaluate the occurrence of mycotic infection in patients with duodenal ulcer on anti-ulcer therapy and to compare the effects of cimetidine, famotidine, and omeprazole." | 9.08 | Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine, famotidine, and omeprazole. ( Chakrabarti, A; Goenka, MK; Gupta, O; Kochhar, R; Kumar, A; Mehta, SK; Talwar, P, 1996) |
" Our purpose was to evaluate the occurrence of mycotic infection in patients with duodenal ulcer on anti-ulcer therapy and to compare the effects of cimetidine, famotidine, and omeprazole." | 5.08 | Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine, famotidine, and omeprazole. ( Chakrabarti, A; Goenka, MK; Gupta, O; Kochhar, R; Kumar, A; Mehta, SK; Talwar, P, 1996) |
" He was successfully treated by increasing his dosage of omeprazol (20 mg/day) for two weeks." | 1.35 | Acute gastroduodenal injury after ingestion of diluted herbicide pendimethalin. ( Azuhata, H; Katoh, H; Kuwano, H; Tsukada, K, 2009) |
"Forty of 78 patients dying of oesophageal cancer had the disease present at registration." | 1.32 | Mortality study of 18 000 patients treated with omeprazole. ( Bateman, DN; Colin-Jones, D; Hartz, S; Langman, M; Logan, RF; Mant, J; Murphy, M; Paterson, KR; Rowsell, R; Thomas, S; Vessey, M, 2003) |
" In a group of 34 patients studied prospectively, high dosage (300 mg orally bid) therapy with the H2-antagonist ranitidine for 8 wk significantly improved symptoms and endoscopic appearance (p < 0." | 1.29 | Clinical and pathologic features of the nodular duodenum. ( Triadafilopoulos, G, 1993) |
"A case of ulcerative colitis complicated with gastric and duodenal lesions is reported." | 1.29 | Ulcerative colitis complicated by gastroduodenal lesions. ( Bamba, T; Fujiyama, Y; Inoue, H; Koyama, S; Okada, K; Sasaki, M; Yoshioka, U, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (40.00) | 18.2507 |
2000's | 9 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tseng, GY | 1 |
Jeng, TK | 1 |
Yang, HB | 1 |
Lin, HJ | 1 |
Burkov, SG | 1 |
Arutiunov, AT | 1 |
Gurova, NIu | 1 |
Lobanova, EG | 1 |
Nikiforov, PA | 1 |
Okoemov, MN | 1 |
Cherezova, IN | 1 |
Chugunnikova, LI | 1 |
Tsukada, K | 1 |
Azuhata, H | 1 |
Katoh, H | 1 |
Kuwano, H | 1 |
Bateman, DN | 1 |
Colin-Jones, D | 1 |
Hartz, S | 1 |
Langman, M | 1 |
Logan, RF | 1 |
Mant, J | 1 |
Murphy, M | 1 |
Paterson, KR | 1 |
Rowsell, R | 1 |
Thomas, S | 1 |
Vessey, M | 1 |
Todd, JA | 1 |
Basu, KK | 1 |
de Caestecker, JS | 1 |
Mégraud, F | 1 |
Triadafilopoulos, G | 1 |
Goenka, MK | 1 |
Kochhar, R | 1 |
Chakrabarti, A | 1 |
Kumar, A | 1 |
Gupta, O | 1 |
Talwar, P | 1 |
Mehta, SK | 1 |
Sasaki, M | 1 |
Okada, K | 1 |
Koyama, S | 1 |
Yoshioka, U | 1 |
Inoue, H | 1 |
Fujiyama, Y | 1 |
Bamba, T | 1 |
De Francesco, V | 1 |
Stoppino, V | 1 |
Germano, MP | 1 |
Frigerio, P | 1 |
De Paolis, PL | 1 |
Faleo, D | 1 |
Sugimoto, M | 1 |
Kajimura, M | 1 |
Hanai, H | 1 |
Kaneko, E | 1 |
Pilotto, A | 1 |
Di Mario, F | 1 |
Franceschi, M | 1 |
Leandro, G | 1 |
Battaglia, G | 1 |
Germanà, B | 1 |
Marin, R | 1 |
Valerio, G | 1 |
Miehsler, W | 1 |
Püspök, A | 1 |
Oberhuber, T | 1 |
Vogelsang, H | 1 |
Chan, KL | 1 |
Zhou, H | 1 |
Ng, DK | 1 |
Tam, PK | 1 |
Gabbrielli, M | 1 |
Pennati, P | 1 |
Trallori, G | 1 |
Vannozzi, G | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Personalized Treatment for Refractory H Pylori Infection[NCT02547025] | 126 participants (Actual) | Interventional | 2012-08-01 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for omeprazole and Duodenal Diseases
Article | Year |
---|---|
Adjuvant therapy for Helicobacter pylori eradication: role of lansoprazole shown in vitro.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Cells, Cultured; Chemotherapy, Adjuvant; Duodenal | 1995 |
4 trials available for omeprazole and Duodenal Diseases
Article | Year |
---|---|
[NSAID-gastropathy: state-of-the-art therapy optimization capabilities in outpatient practice].
Topics: Adult; Aged; Ambulatory Care; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Drug Admin | 2008 |
Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus.
Topics: Aged; Anti-Ulcer Agents; Barrett Esophagus; Duodenal Diseases; Esophagoscopy; Esophagus; Female; Gas | 2005 |
Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine, famotidine, and omeprazole.
Topics: Adult; Anti-Ulcer Agents; Candidiasis; Cimetidine; Duodenal Diseases; Duodenal Ulcer; Famotidine; Fe | 1996 |
Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Aging; Amoxicillin; Anti-Bacterial Agent | 2000 |
10 other studies available for omeprazole and Duodenal Diseases
Article | Year |
---|---|
Is there a role for intravenous omeprazole in patients with duodenal diverticular bleeding after successful initial endoscopic hemostasis?
Topics: Combined Modality Therapy; Diverticulum; Dose-Response Relationship, Drug; Drug Administration Sched | 2008 |
Acute gastroduodenal injury after ingestion of diluted herbicide pendimethalin.
Topics: Accidents, Home; Acute Disease; Aged; Aniline Compounds; Anti-Ulcer Agents; Duodenal Diseases; Herbi | 2009 |
Mortality study of 18 000 patients treated with omeprazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cause of Death; Child; Duodenal Disea | 2003 |
Clinical and pathologic features of the nodular duodenum.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Duodenal Diseases; Duodenitis; Duodenoscopy; Duodenum; Human | 1993 |
Ulcerative colitis complicated by gastroduodenal lesions.
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Ulcer Agents; Colitis, Ulcerative; Duodenal Diseases; Duo | 1996 |
Ulcer activity but not duodenal stenosis regresses after eradication of Helicobacter pylori.
Topics: Adult; Anti-Ulcer Agents; Duodenal Diseases; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies | 1999 |
Prevention of hemorrhage from intradiverticular ulcer in the duodenum by Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diverticulum; Drug Ther | 2000 |
Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Crohn Disease; Data Interpretatio | 2001 |
A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; C | 2001 |
Use of intravenous omeprazole in emergency cases of gastroduodenal hemorrhage.
Topics: Duodenal Diseases; Emergencies; Female; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous | 1992 |